Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


Clear sponsor disquiet at PBAC

Posted 21 December 2020 AM

Sponsor disquiet at the PBAC's continued rejection of requests for listing of major new medicines has emerged strongly from November meeting outcomes released on Friday.

Expressions of disappointment, surprise and one abandonment of further listing attempts were among sponsor reactions to the reimbursement committee's negative decisions.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Biden and the MA agreement
'Global decisions' will influence ongoing negotiations
Special Report
PBAC March agenda
Every major and minor sub sorted by indication
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas